Table 5

Characteristics of the patients (n=491) included in the validation cohort

Patient characteristicsStatistical data and measurements
Age (year)58.1 (SD 10.71)
Male344 (70.1%)
BMI (kg/m²)26.67 (SD 6.30)
In-hospital mortality144 (29.33%)
Time to death14.6 (SD 11.32)
Liver transplantation23 (4.68%)
Time to transplantation9.41 (SD 6.18)
Reason for hospitalisation at the ICU
Hepatic encephalopathy251 (51.12%)
Respiratory insufficiency161 (32.80%)
Circulatory insufficiency79 (16.09%)
Requirement of organ support
Renal replacement therapy161 (32.79%)
Mechanical ventilation135 (27.49%)
Need for vasopressors160 (32.59%)
Heart rate (/min)87.58 (SD 18.85)
Blood pressure (sys.)109.29 (SD 22.51)
Lowest MAP in the first hour76.10 (SD 15.92)
Respiratory rate (per min)18.35 (SD 5.60)
PaO2/FiO2353.77 (SD 114.71)
Albumin (g/L)24.00 (q1 20.00, q3 29.35)
Bilirubin (mg/dL)4.9 (q1 2.10, q3 12.70)
Creatinine (mg/dL)1.58 (q1 0.98, q3 2.65)
C reactive protein (mg/L)31.10 (q1 12.90, q3 68.30)
GFR (mL/min/1.73 m2; CKD-EPI)46.00 (q1 24.00, q3 76.00)
Highest lactate in the first hour (mmol/L)1.89 (q1 1.33, q3 2.89)
Na (mmol/L)138.00 (q1 133.00, q3 142.00)
Platelet count (per nL)77.00 (q1 48.00, q3 119.00)
Procalcitonin (g/mL)0.41 (q1 0.17, q3 1.00)
Prothrombin time (%)44.00 (q1 34.00, q3 55.00)
Urea (mmol/L)83.00 (q1 47.00, q3 134.00)
Pre-existing TIPS135 (27%)
CP count10.73 (SD 2.01)
CP class
Child A8 (2%)
Child B117 (24%)
Child C366 (74%)
MELD score25.24 (SD 9.03)
ACLF295 (60.1%)
CLIF-C ACLF54.1 (SD 9.40)
ACLF grade2.1 (SD 0.82)
SOFA8.61 (SD 4.16)
qSOFA0.99 (SD 0.81)
Septic shock79 (16.1%)
SAPS II28.25 (SD 12.35)
  • ACLF, acute-on-chronic liver failure; BMI, Body Mass Index; CKD-EPI, chronic kidney disease epidemiology; CLIF-C ACLF, CLIF consortium acute-on-chronic liver failure; CP, Child-Pugh; GFR, glomerular filtration rate; ICU, intensive care unit; MAP, mean arterial pressure; MELD, Model for End-Stage Liver Disease; qSOFA, quick SOFA; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; TIPS, transjugular intrahepatic portosystemic shunt.